Bizarre Patents
A hand wearable body squeegee comprising a glove portion, a concave squeegee band, and a linear squeegee band.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8173792 | Method for regulating protein function in cells using synthetic small molecules Methods and compositions for the rapid and reversible destabilizing of specific proteins using cell-permeable, synthetic molecules are described. Stability-affecting proteins, e.g., derived from FKBP and DHFR proteins are fused to a protein of interest and the prese... | 05/08/2012 |
| 8173020 | Method for removing contaminants from water using a membrane biofilm reactor Apparatus and methods for water treatment are described, particularly for the simultaneous removal of nitrate, perchlorate, and other organic contaminates from contaminated water using a membrane biofilm reactor (MBfR). ... | 05/08/2012 |
| 8148071 | Methods and compositions for isolating nucleic acid The present invention relates to compositions and methods for isolating and purifying nucleic acid. In particular, the present invention relates to methods of isolating nucleic acid from cells for use in further analysis. ... | 04/03/2012 |
| 8129510 | Minigene expression cassette Methods and compositions for expressing a gene or nucleotide sequence of interest are provided. The compositions include an expression cassette that includes a synthetic enhancer, a transthyretin promoter, and a nucleotide sequence operably under the control of the ... | 03/06/2012 |
| 8119166 | Methods of treatment using a gastric retained gabapentin dosage A method of treatment for epilepsy and other disease states is described, which comprises delivery of gabapentin in a gastric retained dosage form. ... | 02/21/2012 |
| 8109014 | Foot orthotic devices A foot orthotic device is disclosed. More specifically described is an individualized foot orthotic device to correct and/or restore the ideal alignment and/or positioning of foot structures. The device is designed using a method and system that applies sequential p... | 02/07/2012 |
| 8083969 | Thermally-responsive materials and devices comprising such materials Devices are described that include a component comprised of a material having a structure of R1—C(O)—NX—R2, wherein each of R1 and R2 is independently a saturated alkyl having between 7-22 carbon atoms or an aryl, X ... | 12/27/2011 |
| 8075501 | Methods for designing a foot orthotic Disclosed are methods and systems for design of a foot orthotic, and a foot orthotic device designed in accord therewith. More specifically described is an individualized foot orthotic device to correct and/or restore the ideal alignment and/or positioning of foot s... | 12/13/2011 |
| 8067532 | Modifications of peptide compositions to increase stability and delivery efficiency The disclosed invention relates to methods of modifying peptide compositions to increase stability and delivery efficiency. Specifically, the disclosed invention relates to methods to increase the stability and delivery efficiency of protein kinase C (PKC) modulator... | 11/29/2011 |
| 8067014 | Chimeric AAV capsid proteins Recombinant adeno-associated viral (AAV) capsid proteins are provided. Methods for generating the recombinant adeno-associated viral capsid proteins and a library from which the capsids are selected are also provided. ... | 11/29/2011 |
| 8043630 | Shell-and-core dosage form approaching zero-order drug release Drugs are formulated as oral dosage forms for controlled release in which the release rate limiting portion is a shell surrounding the drug-containing core. The shell releases drug from the core by permitting diffusion of the drug from the core. The shell also motes... | 10/25/2011 |
| 8034922 | Compositions and methods for modulating activity of capped small RNAs Compositions and methods for modulating transcription by RNA polymerases are described. ... | 10/11/2011 |
| 8030091 | Method for adding an apparent non-signal line to a rapid diagnostic assay A test device and method for determining the presence or absence of one or more analytes in a fluid sample, the test device including a support or member bearing a mark thereon, and a matrix or member containing a capture zone. In operation, an observation area in t... | 10/04/2011 |
| 7994133 | Isozyme-specific antagonists of protein kinase C A method of changing or otherwise converting the biological activity of a PKC peptide agonist to a peptide antagonist is described. The method involves substituting one or more amino acid residues so as to effect a change in charge in the peptide and/or to otherwise... | 08/09/2011 |
| 7985726 | ψεRACK peptide composition and method for protection against tissue damage due to ischemia A method of reducing damage to cells and tissue caused by an ischemic or hypoxic event is disclosed. The method includes administering to the cell or tissue, either in vivo or ex vivo, ψεRACK peptide. The peptide can be administered before, during or after the isc... | 07/26/2011 |
| 7976870 | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract Controlled release oral dosage forms are provided for the continuous, sustained administration of a pharmacologically active agent to the upper gastrointestinal tract of a patient in whom the fed mode as been induced. The majority of the agent is delivered, on an ex... | 07/12/2011 |
| 7939493 | Peptide inhibitors of protein kinase C PKC V5 isozyme-specific peptides are described. The sequences and compositions comprising the sequences are useful for treating disease states associated with the PKC isozyme from which they are respectively derived. Methods of treatment, pharmaceutical formulations... | 05/10/2011 |
| 7931807 | Method for removing contaminants from ground water Apparatus and methods for water treatment are described, particularly for the simultaneous removal of nitrate, perchlorate, and other organic contaminates from contaminated water using a membrane biofilm reactor (MBfR). ... | 04/26/2011 |
| 7926363 | Systems for designing a foot orthotic Disclosed are methods and systems for design of a foot orthotic, and a foot orthotic device designed in accord therewith. More specifically described is an individualized foot orthotic device to correct and/or restore the ideal alignment and/or positioning of foot s... | 04/19/2011 |
| 7914480 | Transdermal delivery device A dermal, transdermal, mucosal or transmucosal delivery device includes a backing layer overlying an ingredient containing reservoir, and having a microprotrusion array attached thereto, a cover for the reservoir having at least one opening therethrough, an adhesive... | 03/29/2011 |
| 7871568 | Rapid test apparatus Provided herein are methods and devices for rapid testing of solid, semi-solid, or liquid specimens, such as stool, blood, urine, saliva, or swab specimens of the cervix, urethra, nostril, and throat, and for environmental testing. ... | 01/18/2011 |
| 7833984 | Peptide inhibitors of protein kinase C PKC V5 isozyme-specific peptides are described. The sequences and compositions comprising the sequences are useful for treating disease states associated with the PKC isozyme from which they are respectively derived. Methods of treatment, pharmaceutical formulations... | 11/16/2010 |
| 7815801 | Removal of selenium in contaminated wastewater streams Compositions and methods for the removal of selenium species from water containing high-salt concentrations and/or petroleum contaminants are described. The compositions and methods use a selenium-reducing microorganism adapted to adverse environments. ... | 10/19/2010 |
| 7807202 | Compositions for treatment of viral-induced skin lesions and methods of using same A composition and method for treatment of viral-induced skin lesions, such as warts, are described. The composition is comprised of tea tree oil and/or derivatives from tea tree oil and one or more minerals, such as iodide and/or selenium. The composition is used to... | 10/05/2010 |
| 7803775 | Protein kinase C peptides for use in withdrawal A method for managing withdrawal from an addictive substance is described. The method involves administering one or more peptides having specific activity for the ε and/or γ isozyme of protein kinase C (PKC). The peptide(s) can be administered prior to, concurrent... | 09/28/2010 |
| 7794657 | Phase change sensor A device is disclosed which is a highly sensitive and selective sensor. The device is comprised of a sensor material secured into a fixed position on substrate, a deformable arm and a signaling component which creates a detectable signal in response to movement of t... | 09/14/2010 |
| 7794656 | Device for handling and analysis of a biological sample An apparatus for detection of an analyte of interest in a solid, semi-solid, or liquid biological sample, using a lateral flow assay test strip, is described. The apparatus minimizes sample handling and manipulation upon introduction of the sample into a sample-rece... | 09/14/2010 |
| 7745412 | Isozyme-specific antagonists of protein kinase C A method of changing or otherwise converting the biological activity of a PKC peptide agonist to a peptide antagonist is described. The method involves substituting one or more amino acid residues so as to effect a change in charge in the peptide and/or to otherwise... | 06/29/2010 |
| 7741290 | Method of preventing progression of hypertension-induced heart failure with PKC peptides Methods are described for slowing or inhibiting the progression of heart failure in a mammalian subject suffering from chronic hypertension. The methods involve administering an εPKC, β1PKC, or βIIPKC peptide inhibitor, examples of which are provided. ... | 06/22/2010 |
| 7736667 | Shell-and-core dosage form approaching zero-order drug release Drugs are formulated as oral dosage forms for controlled release in which the release rate limiting portion is a shell surrounding the drug-containing core. The shell releases drug from the core by permitting diffusion of the drug from the core. The shell also promo... | 06/15/2010 |
| 7731989 | Gastric retained gabapentin dosage form A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form. ... | 06/08/2010 |
| 7695710 | Antitumor and antiviral combination therapies using low-toxicity, long-circulating human interferon-alpha analogs Interferon-alpha (IFNα) analog proteins modified by chemical attachment of at least one hydrophilic polymer moiety, such as polyethylene glycol chain, are described for use in combination therapies with antiviral and/or antitumor agents. In one embodiment, the IFNÎ... | 04/13/2010 |
| 7691644 | Devices for the detection of multiple analytes in a sample The present invention relates generally to an assay for detecting and differentiating multiple analytes, if present, in a single fluid sample, including devices and methods therefore. ... | 04/06/2010 |
| 7662370 | Low-toxicity, long-circulating human interferon-alpha PEGylated mutants Interferon-alpha (IFNα) analog proteins modified by chemical attachment of at least one hydrophilic polymer moiety, such as polyethylene glycol chain, are described. In one embodiment, the IFNα analog protein has an amino acid sequence that differs from a native h... | 02/16/2010 |
| 7638915 | Modular magneto-mechanical device An electromechanical device has a rotor, a stator, and a module that at least partially houses the rotor. During normal operation of the electromechanical device, the stator is positioned external to and separate from the module. ... | 12/29/2009 |
| D606664 | Assay device and housing combined | 12/22/2009 |
| 7632687 | Hybrid phase lateral flow assay The invention relates to devices for performing single step assays for the determination of the presence or absence of an analyte in a liquid sample, and methods of determining the presence or absence of such analytes using such devices. Devices disclosed comprise a... | 12/15/2009 |
| 7618537 | Membrane biofilm reactor method for reducing the concentration of oxidized contaminants in ground water Apparatus and methods for water treatment are described, particularly for the simultaneous removal of nitrate, perchlorate, and other organic contaminates from contaminated water using a membrane biofilm reactor (MBfR). ... | 11/17/2009 |
| 7612112 | Methods of treatment using a gastric retained gabapentin dosage A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form. ... | 11/03/2009 |
| 7588772 | AAV capsid library and AAV capsid proteins Recombinant adeno-associated viral (AAV) capsid proteins are provided. Methods for generating the recombinant adeno-associated viral capsid proteins and a library from which the capsids are selected are also provided. ... | 09/15/2009 |
